StockData
Insight Molecular Diagnostics Inc. logo

Insight Molecular Diagnostics Inc. (IMDX) stock

IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.59−0.19 (-10.67%)

Close on Nov 18, 2026Market cap $52.03MP/E –Yield –

Insight Molecular Diagnostics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Insight Molecular Diagnostics's market cap was $77.97M on Nov 11, 2026, against $175.76M a year earlier. Over the last 5 years it ranged from $18.82M to $214.69M, with a median of $72.07M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$77.97M-63.7%
2025Dec 31, 2025$214.69M+574.5%
2024Dec 31, 2024$31.83M+54.1%
2023Dec 29, 2023$20.65M-45.7%
2022Dec 30, 2022$38.06M-81.0%
2021Dec 31, 2021$199.98M+24.4%
2020Dec 31, 2020$160.73M+37.4%
2019Dec 31, 2019$116.94M+108.4%
2018Dec 31, 2018$56.12M-61.6%
2017Dec 29, 2017$146.09M-27.7%
2016Dec 30, 2016$202.17M+77.7%
2015Dec 31, 2015$113.75M–

More Insight Molecular Diagnostics figures

See a number that looks wrong?